Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 2Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 129Precursor Cell Lymphoblastic Leukemia-Lymphoma 81Hematologic Neoplasms 66Leukemia, Lymphocytic, Chronic, B-Cell 65Leukemia 53Myelodysplastic Syndromes 49Lymphoma 34Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Lymphoma, Non-Hodgkin 29Multiple Myeloma 21Burkitt Lymphoma 21Leukemia, Myelomonocytic, Chronic 20Recurrence 18Neoplasms 18Lymphoma, Large B-Cell, Diffuse 15Leukemia, B-Cell 14Hodgkin Disease 14Myeloproliferative Disorders 13Lymphoma, Mantle-Cell 12Leukemia, Biphenotypic, Acute 12Lymphoma, Follicular 11Lymphoma, B-Cell 11Waldenstrom Macroglobulinemia 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, B-Cell, Marginal Zone 10Anemia, Refractory, with Excess of Blasts 10Blast Crisis 8Primary Myelofibrosis 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic-Myeloproliferative Diseases 6

Interventions

Cyclophosphamide 2pembrolizumab 1fludarabine phosphate 1fludarabine 1Surveys and Questionnaires 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Leukemia, Lymphoid × Other hematologic neoplasm × 30 days × Clear all
NCT05865301 2026-06-04

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

Stanford University

Recruiting
500 enrolled
Other hematologic neoplasm

Leukemia, Lymphoid

NCT03219450 2026-05-28

A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.

Dana-Farber Cancer Institute

Phase 1 Recruiting
15 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Lymphoid

NCT03573700 2026-05-20

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

St. Jude Children's Research Hospital

Phase 1/2 Active not recruiting
24 enrolled 9 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphoid, Recurrence, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07566364 2026-05-20

Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD

M.D. Anderson Cancer Center

Phase 2 Not yet recruiting
30 enrolled
Other hematologic neoplasm

Leukemia, Lymphoid

NCT07292272 2026-05-18

HALTAging-1

University of Nebraska

Phase 2 Recruiting
180 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡